Abatacept para la artritis reumatoide
Información
- DOI:
- https://doi.org/10.1002/14651858.CD007277.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Salud musculoesquelética
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
LM drafted the protocol, JAS provided comments
Review of abstracts ‐ LM, JAS
Data abstraction ‐ LM, JAS
Assessment of study quality ‐ LM, JAS
Review draft ‐ LM
Draft revision ‐ LM, JAS
Sources of support
Internal sources
-
University of Ottawa, Canada.
-
Minneapolis VA Medical Center, USA.
External sources
-
No sources of support supplied
Declarations of interest
None known. This systematic review did not receive specific funding.
Acknowledgements
Thanks to Louise Falzon, Trials Search Co‐ordinator of the Cochrane Musculoskeletal Group, and Nancy Santesso for providing comments on the search strategy. This systematic review was conducted as part of a course on systematic review methodology, taught by Dean Fergusson and David Moher, in the Masters of Epidemiology and Community Medicine program at the University of Ottawa.
Version history
| Published | Title | Stage | Authors | Version |
| 2009 Oct 07 | Abatacept for rheumatoid arthritis | Review | Lara Maxwell, Jasvinder A Singh | |
| 2009 Jul 08 | Abatacept for rheumatoid arthritis | Protocol | Lara Maxwell, Jasvinder A Singh | |
Differences between protocol and review
We undertook a subgroup analysis of adverse events in patients on a background therapy of biologics. This analysis was not prespecified in the protocol but arose out of a concern from one of the included studies which analysed their results by background therapy (non‐biologic versus biologic).
